These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19911445)

  • 1. Using conjoint analysis to estimate healthy-year equivalents for acute conditions: an application to vasomotor symptoms.
    Johnson FR; Hauber AB; Ozdemir S
    Value Health; 2009; 12(1):146-52. PubMed ID: 19911445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthy-year equivalents in major joint replacement. Can patients provide meaningful responses?
    Llewellyn-Thomas HA; Arshinoff R; Bell M; Williams JI; Naylor CD
    Int J Technol Assess Health Care; 2002; 18(3):467-84. PubMed ID: 12391941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States.
    Williams RE; Kalilani L; DiBenedetti DB; Zhou X; Granger AL; Fehnel SE; Levine KB; Jordan J; Clark RV
    Climacteric; 2008 Feb; 11(1):32-43. PubMed ID: 18202963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of vasomotor symptoms in middle-aged women: a longitudinal study.
    Col NF; Guthrie JR; Politi M; Dennerstein L
    Menopause; 2009; 16(3):453-7. PubMed ID: 19188852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review.
    Utian WH
    Health Qual Life Outcomes; 2005 Aug; 3():47. PubMed ID: 16083502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Women's willingness to accept perceived risks for vasomotor symptom relief.
    Johnson FR; Ozdemir S; Hauber B; Kauf TL
    J Womens Health (Larchmt); 2007 Sep; 16(7):1028-40. PubMed ID: 17903080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of sublingual and topical compounded bioidentical hormone replacement therapy in postmenopausal women: an observational cohort study.
    Ruiz AD; Daniels KR
    Int J Pharm Compd; 2014; 18(1):70-7. PubMed ID: 24881343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life of women with menopausal hot flushes and night sweats.
    Ayers B; Hunter MS
    Climacteric; 2013 Apr; 16(2):235-9. PubMed ID: 22809134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menopausal hot flushes and night sweats: where are we now?
    Archer DF; Sturdee DW; Baber R; de Villiers TJ; Pines A; Freedman RR; Gompel A; Hickey M; Hunter MS; Lobo RA; Lumsden MA; MacLennan AH; Maki P; Palacios S; Shah D; Villaseca P; Warren M
    Climacteric; 2011 Oct; 14(5):515-28. PubMed ID: 21848495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transition from estrogen-progestin to raloxifene in postmenopausal women: effect on vasomotor symptoms.
    Gordon S; Walsh BW; Ciaccia AV; Siddhanti S; Rosen AS; Plouffe L
    Obstet Gynecol; 2004 Feb; 103(2):267-73. PubMed ID: 14754694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QALYs, HYEs and individual preferences--a graphical illustration.
    Johannesson M
    Soc Sci Med; 1994 Dec; 39(12):1623-32. PubMed ID: 7846559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of micronutrient supplementation on vasomotor symptoms in postmenopausal women.
    Andrikoula M; Baker D; Nesic J; Liao LM; Duka T; Prelevic GM
    Climacteric; 2011 Oct; 14(5):544-50. PubMed ID: 21413865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying meaningful differences in vasomotor symptoms among menopausal women.
    Wyrwich KW; Spratt DI; Gass M; Yu H; Bobula JD
    Menopause; 2008; 15(4 Pt 1):698-705. PubMed ID: 18369313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal decrease in hot flashes desired by postmenopausal women in family practice.
    Butt DA; Deng LY; Lewis JE; Lock M
    Menopause; 2007; 14(2):203-7. PubMed ID: 17099324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo.
    Kwee SH; Tan HH; Marsman A; Wauters C
    Maturitas; 2007 Sep; 58(1):83-90. PubMed ID: 17689896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Premenstrual symptoms in fertile age are associated with impaired quality of life, but not hot flashes, in recently postmenopausal women.
    Hautamäki H; Haapalahti P; Savolainen-Peltonen H; Tuomikoski P; Ylikorkala O; Mikkola TS
    Menopause; 2014 Dec; 21(12):1287-91. PubMed ID: 24824645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the severity of vasomotor symptoms on health status, resource use, and productivity.
    Whiteley J; Wagner JS; Bushmakin A; Kopenhafer L; Dibonaventura M; Racketa J
    Menopause; 2013 May; 20(5):518-24. PubMed ID: 23403500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasomotor symptoms in menopause: where we've been and where we're going.
    Pinkerton JV; Zion AS
    J Womens Health (Larchmt); 2006 Mar; 15(2):135-45. PubMed ID: 16536677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasomotor symptoms and mortality: the Rancho Bernardo Study.
    Svartberg J; von Mühlen D; Kritz-Silverstein D; Barrett-Connor E
    Menopause; 2009; 16(5):888-91. PubMed ID: 19421076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled study of taper-down or abrupt discontinuation of hormone therapy in women treated for vasomotor symptoms.
    Lindh-Astrand L; Bixo M; Hirschberg AL; Sundström-Poromaa I; Hammar M
    Menopause; 2010; 17(1):72-9. PubMed ID: 19675505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.